fosfomycin and Dysentery--Bacillary

fosfomycin has been researched along with Dysentery--Bacillary* in 3 studies

Trials

1 trial(s) available for fosfomycin and Dysentery--Bacillary

ArticleYear
[Comparison of clinical efficacy of fosfomycin (FOM) and kanamycin (KM) in bacillary dysentery by double blind method (author's transl)].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1980, Volume: 54, Issue:7

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Clinical Trials as Topic; Double-Blind Method; Dysentery, Bacillary; Female; Fosfomycin; Humans; Kanamycin; Male; Middle Aged

1980

Other Studies

2 other study(ies) available for fosfomycin and Dysentery--Bacillary

ArticleYear
Characterization of Extended-Spectrum β-Lactamase Genes of Shigella flexneri Isolates With Fosfomycin Resistance From Patients in China.
    Annals of laboratory medicine, 2017, Volume: 37, Issue:5

    The emergence of fosfomycin resistance and extended-spectrum β-lactamase (ESBL) genes is a serious threat to public health and a new challenge in shigellosis treatment. The purpose of this study was to identify fosfomycin resistance and characterize β-lactamase genes in fos-carrying isolates of Shigella flexneri from patients in China.. A total of 263 S. flexneri isolates were collected from 34 hospitals in the Anhui Province of China during September 2012-September 2015 and screened for fosA3, fosA, and fosC2 by PCR amplification and sequencing. The fos-carrying isolates were then screened for β-lactamase genes. The clonal relationships between fosA3-carrying isolates, the transmissibility of fosfomycin resistance, replicon types of plasmids carrying fosfomycin resistance genes and other associated resistance genes were investigated.. Twenty-five of the 263 isolates (9.5%) showed resistance to fosfomycin, and 18 (6.8%) were positive for fosA3. None of the isolates was positive for fosA or fosC2. Seventeen of the isolates carrying fosA3 (94%) were CTX-M producers (seven CTX-M-55, five CTX-M-14, and five CTX-M-123), while three (16.7%) were TEM producers (TEM-1).Sixteen (88.9%) fosA3-carrying isolates exhibited multi-drug resistance. The replicon types of the 13 fosA3-carrying plasmids were IncF (n=13), IncHI2 (n=3), IncIl-Ir (n=2), and IncN (n=1).. Our results indicated that fosA3 could spread through plasmids in S. flexneri isolates, along with the bla(CTX-M) and bla(TEM), which facilitate its quick dispersal. To the best of our knowledge, this is the first report of CTX-M-123-type ESBLs in S. flexneri isolates from patients in China.

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Fosfomycin; Genotype; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Shigella flexneri

2017
[Therapeutic effect of fosfomycin on bacillary dysentery and related enterocolitic infections].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1975, Volume: 49, Issue:12

    Topics: Adolescent; Anti-Bacterial Agents; Child; Drug Evaluation; Dysentery, Bacillary; Female; Fosfomycin; Humans; Male; Salmonella Infections

1975